Spinal cord attacks predict worse disability in NMOSD, MOGAD
Attacks marked by spinal cord inflammation significantly increase the chance of worse disability in NMOSD and MOGAD, per a study.| Neuromyelitis News
Attacks marked by spinal cord inflammation significantly increase the chance of worse disability in NMOSD and MOGAD, per a study.| Neuromyelitis News
Patricia Inacio is a science writer for Neuromyelitis News with a PhD in cell biology. She covers the latest news and information on a variety of NMO topics.| Neuromyelitis News
Columnist Jennifer van Amerom reflects on married life with NMO, and expresses her gratitude for her husband, Mike.| Neuromyelitis News
Uplizna is an FDA-approved treatment for adults with neuromyletis optica spectrum disorder who test positive for AQP4-IgG antibodies.| Neuromyelitis News
Category archive page for Columns.| Neuromyelitis News
While neuromyelitis optica spectrum disorder's causes are not fully understood, self-reactive antibodies against AQP4 are known major drivers.| Neuromyelitis News
Category archive page for News.| Neuromyelitis News
